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Multivesicular endosomes/bodies (MVBs) sort membrane proteins between recycling and
degradative pathways. Segregation of membrane proteins onto intraluminal vesicles (ILVs)
of MVBs removes them from the recycling pathway and facilitates their degradation fol-
lowing fusion of MVBs with lysosomes. Sorting of many cargos onto ILVs depends on
the ESCRT (Endosomal Sorting Complex Required for Transport) machinery, although
ESCRT-independent mechanisms also exist. In mammalian cells, efﬁcient sorting of
ligand-stimulated epidermal growth factor receptors onto ILVs also depends on the tyro-
sine phosphatase, PTP1B, an ER-localised enzyme that interacts with endosomal targets
at membrane contacts between MVBs and the ER. This review focuses on the potential
roles played by ER :MVB membrane contact sites in regulating ESCRT-dependent ILV
formation.
Introduction
ESCRT (Endosomal Sorting Complex Required for Transport)-dependent sorting of ubiquitinated
EGF (epidermal growth factor) receptor (EGFR) onto intraluminal vesicles (ILVs) of multivesicular
endosomes/bodies (MVBs) plays an important role in down-regulation of EGFR signalling by remov-
ing the catalytic domain of the receptor from the cytoplasm and targeting the receptor for degrad-
ation. EGF stimulation of EGFR promotes not only the incorporation of the receptor onto ILVs but
also the formation of the ILVs themselves [1]. EGF-stimulated ILV formation depends on the ESCRT
machinery since depletion of ESCRT components inhibits EGF-stimulated ILV formation [2].
Furthermore, a poorly ubiquitinated EGFR that is impaired in its ability to recruit ESCRT0 is unable
to promote EGF-stimulated ILV formation [3]. Depletion of ubiquitinated cargo in yeast has been
shown to inhibit ILV formation [4], and so, the presence of increased ubiquitinated cargo (EGFR) on
the limiting membrane of MVBs following EGF stimulation could contribute to the increased ILV for-
mation. However, this is unlikely to be the sole explanation of enhanced ILV formation in
EGF-stimulated cells because we have identiﬁed two proteins, annexin A1 and protein tyrosine phos-
phatase 1B (PTP1B), that are not normally considered part of the ESCRT machinery, but are absolute
requirements for EGF-stimulated ILV formation [1,5].
Roles of annexin A1 and PTP1B in EGF-stimulated ILV
formation
In studies that preceded the identiﬁcation of the ESCRT machinery, the activity of the EGFR kinase
was shown to be necessary for efﬁcient targeting of EGFR onto ILVs [6], leading us to search for sub-
strates of the EGFR kinase associated with MVBs. We showed that the calcium and phospholipid-
binding protein, annexin A1, associated with EGFR-containing MVBs where it underwent
EGF-stimulated phosphorylation [7] and found that annexin A1 depletion or knockout had no effect
on ILV formation in resting cells, but abolished EGF-stimulated ILV formation [1]. EGF-stimulated
ILV formation could be rescued by re-expression of wild-type annexin A1 but not a mutant lacking
the single tyrosine phosphorylation site in the N-terminus of the protein. Annexin A1 has been
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shown to mediate membrane aggregation in vitro [8], leading us to suggest models whereby annexin A1 mole-
cules on opposing membranes of deeply invaginating buds might help to promote vesicle scission [9].
However, a subsequent investigation into the role of the protein tyrosine phosphatase, PTP1B, which depho-
sphorylates EGFR, led us to a quite different view of the role of annexin A1.
PTP1B is embedded in the cytoplasmic face of the ER and yet Haj et al. [10] showed that endocytosed
EGFR interacts with PTP1B, raising the question of how these two proteins on different organelles interact. By
expressing a substrate-trapping mutant of PTP1B that prolongs what would normally be a very transient inter-
action between the phosphatase and its substrate, we were able to show that this interaction occurs at mem-
brane contact sites between the ER and EGFR-containing MVBs [5] (Figure 1). The ER forms membrane
contacts with virtually every organelle within the cell and the last decade has seen an explosion in our under-
standing of membrane contact site biology and in the formation and function of contacts between the ER and
the endocytic pathway (Table 1). Depleting cells of PTP1B not only prolonged phosphorylation of endocytosed
EGFR but also, like annexin A1 depletion, inhibited EGF-stimulated ILV formation [5]. Given the potential for
annexin A1 to aggregate membranes, this raised the possibility that annexin A1 may regulate membrane
contact site formation between the ER and EGFR-containing MVBs and the further intriguing possibility that
membrane contact sites are required for EGF-stimulated ILV formation.
Annexin A1 regulates membrane contact site formation
between the ER and EGFR-containing MVBs
We have previously shown that EGFRs are trafﬁcked in a subset of MVBs [1], but membrane contacts with the
ER are not conﬁned to this subset of MVBs. We and others have found that the ER makes contacts with mul-
tiple components of the endocytic pathway [5,11–15], with the frequency/extent of contacts increasing with
progression along the pathway to the lysosome [16]. We have further shown that ER contacts with
EGFR-containing MVBs, non-EGFR-containing MVBs and lysosomes are biochemically distinct, since deple-
tion of annexin A1, or its ligand S100A11, has no effect on contacts with non-EGFR–MVBs and lysosomes,
but dramatically impairs the formation of ER contacts with EGFR-containing MVBs [11]. Annexin A1 forms a
tetrameric complex with S100A11 and both components localise to the contacts, consistent with this complex
tethering the contacts. Also consistent with a role for annexin A1 as a tether is the increased contact site forma-
tion upon overexpression of wild-type annexin A1 but not a mutant lacking the EGF-stimulated tyrosine phos-
phorylation site [11]. Conversely, overexpression of a Y21E mutant of annexin A1 that may be a
‘phospho-mimetic’ mutation induced the formation of particularly extended contacts [11]. Mutational analysis
of annexin A1 reveals similar requirements for membrane contact site and EGF-stimulated ILV formation, con-
sistent with EGF-stimulated ILV formation being mediated through phosphorylation of annexin A1 and result-
ing promotion of membrane contact site formation between the ER and EGFR-containing MVBs [11].
How do membrane contact sites regulate ILV formation?
PTP1B-mediated dephosphorylation of endosomal targets
ESCRT-mediated sorting of EGFR begins with the concentration of ubiquitinated EGFR in clathrin-coated
domains on the limiting membrane of MVBs. Clathrin coats and membrane contact sites with the ER are
found on the same MVB, sometimes immediately adjacent to each other [17]. The presence of the clathrin coat
may be a physical barrier to contact site formation, but the temporal relationship between the clathrin coat and
the membrane contact remains unclear. Both recruitment of ubiquitinated EGFR and clathrin into clathrin-
coated domains depends on the ESCRT0 component, Hrs [18,19]. Hrs, and another ESCRT0 component,
STAM1/2, are phosphorylated in response to growth factor stimulation [20] and intriguingly, both Hrs and
STAM1/2 are also subject to dephosphorylation by PTP1B [5,21]. Although Hrs and STAM1/2 are soluble pro-
teins and so would not necessarily require a contact site to interact with PTP1B, Hrs phosphorylation requires
its recruitment to endosomes [22,23] and so would be well placed to be dephosphorylated by PTP1B at ER :
endosome contact sites. The relationship between Hrs phosphorylation state and its ability to recruit clathrin
would be an important indicator of the relationship between contact sites and the clathrin coat.
EGF-stimulated phosphorylation of Hrs was not required for clathrin binding in vitro [24], but whether Hrs
phosphorylation state can directly modulate clathrin binding/dissociation is unclear.
The role of phosphorylation/dephosphorylation of Hrs and STAM1/2 in regulating activity of the ESCRT0
complex is also not clear. Several studies indicate that the major EGF-stimulated tyrosine phosphorylation sites
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within Hrs (Y329 and Y334) are important for efﬁcient progression of EGFR along the endocytic pathway to
the lysosome [23,25] and STAM2 phosphorylation mutants displayed altered endosomal localisation [21]. The
ubiquitin-interacting motif of Hrs, which binds ubiquitinated cargo, is required for EGF-stimulated Hrs phos-
phorylation [23] and can itself become ubiquitinated [26], preventing its interaction with ubiquitinated cargo.
The relationship between Hrs ubiquitination and phosphorylation remains to be fully established, but when
Hrs ubiquitination was enhanced by overexpression of the ubiquitin ligase, c-Cbl, Hrs became hyperphosphory-
lated [25]. Hrs phosphorylation promotes its release from the endosomal membrane [22,27] and could repre-
sent a means to release ubiquitinated Hrs from the MVB-limiting membrane to allow replacement by
Figure 1. Expression of a substrate-trapping mutant of PTP1B promotes the formation of extended membrane contacts
between MVBs and the ER.
HeLa cells transfected with substrate-trapping mutant PTP1B were stimulated with EGF conjugated to horseradish peroxidase
which generates the formation of electron dense reaction product within EGFR-containing MVBs. An extended contact (arrows)
between the ER and the MVB-limiting membrane is shown. Bar: 100 nm.
Table 1 Established roles of ER contacts with endocytic organelles
Established roles of ER contacts with endocytic organelles*
Proteins/complexes involved




ER-localised phosphatase, PTP1B, dephosphorylates
endocytosed EGFR at annexin A1-dependent contacts.
PTP1B : EGFR [5]
annexin A1 : S100A11 [11]
Cholesterol transfer
ER to endosome
In the absence of LDL, ORP1L regulates the transfer of
cholesterol from the ER to the endosome at annexin
A1-dependent contact sites.
ORP1L : VAP
annexin A1 : S100A11 [11]
StARD3 is able to mediate both ER : endosome contacts
and transfer cholesterol from the ER to the endosome.
StARD3 : VAP [44]
Endosomal trafficking
(neurite outgrowth)
ER-localised protrudin interacts with Rab7 to regulate
loading of kinesin-1-promoting plus-end transport towards
the cell periphery.
Protrudin : Rab7 [13]
Endosomal
positioning
Low endosomal cholesterol promotes ORP1L : VAP binding
to induce ER : endosome contact formation where VAP
interacts with Rab7 : RILP. Consequently, dynactin is
removed, promoting microtubule plus-end directed
movement.
VAP : ORP1L : Rab7 : RILP :
dynein(p150Glued) : HOPS [14]
ER-localised E3 ubiquitin ligase RNF26 recruits the ubiquitin
scaffold, p62/SQSTM1, to interact with ubiquitin-binding
domains of vesicle adaptors, restricting vesicles to the
perinuclear region.
RNF26 : SQSTM1 : vesicle
adaptors [50]
Endosome fission VAP interacts with retromer SNX2 subunit and OSBP to
regulate PI4P dynamics affecting actin nucleation and
retromer function.
VAP : SNX2
VAP : OSBP [51]
ER : endosome contacts occur at FAM21-positive sorting
domains immediately before fission events that mediate
budding of tubules for recycling.
FAM21 [52]
*Examples where the membrane contact has been unequivocally shown to be necessary.
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non-ubiquitinated Hrs and further rounds of ubiquitinated cargo sorting. Dephosphorylation of Hrs at mem-
brane contact sites could represent an alternative pathway whereby Hrs becomes dephosphorylated and
de-ubiquitinated in situ at the contact without a requirement for membrane dissociation and subsequent pro-
teasomal degradation. This hypothesis would predict the presence at the contacts of deubiquitinating enzymes,
such as USP8. Loss/depletion of USP8 leads to proteasomal degradation of STAM and Hrs [28–30], but
whether this enzyme operates at membrane contact sites is unclear. PTP1B-mediated Hrs and/or STAM depho-
sphorylation could also be required for progression of cargo through the later ESCRT pathway to ILV forma-
tion either by affecting the ability of Hrs to recruit the ESCRT1 component, Tsg101, or the ability of STAM to
bind another phosphatase, HD-PTP. HD-PTP co-ordinates release of ESCRT0 with recruitment of the deubi-
quitinating enzyme UBPY/USP8 and ESCRTIII through competitive interactions [31] and so is an important
link between ESCRT0 and ILV formation.
Provision of ER-derived cholesterol to support ILV formation when low-density
lipoprotein-derived cholesterol is low
Cholesterol is a cell-wide lipid but its distribution is uneven across different organelle membranes. The plasma
membrane is particularly cholesterol enriched with ∼40% mol compared with the site of synthesis, the ER,
where it is found at 5% mol [32]. Even within a single MVB, cholesterol is found at contrasting levels; ILVs
harbour 85% of total MVB cholesterol [33]. Cholesterol within the endocytic pathway is usually supplied by
low-density lipoprotein (LDL), an extracellular source of cholesterol internalised by receptor-mediated endo-
cytosis. In the absence of LDL, sterol synthesis in the ER is up-regulated through cleavage of sterol regulator
element-binding protein allowing its transport to the nucleus to activate transcription of genes involved in
sterol synthesis and uptake [34,35]. The high cholesterol content of ILVs suggests a role for cholesterol in ILV
formation. Indeed, at least 10% mol cholesterol is necessary for in vitro ESCRTII self-assembly and associated
lipid-phase separation that likely facilitates budding and scission for ILV formation [36]. Consistent with a
cholesterol dependency for ILV formation, we demonstrated a substantial decrease in EGF-stimulated ILV for-
mation upon cholesterol depletion [11]. However, it was necessary to deplete cells of both LDL and ER-derived
cholesterol, implying that in the absence of LDL ER-derived cholesterol supports EGF-stimulated ILV forma-
tion [11]. The potential role of ER : endosome contacts in lipid exchange raised the possibility that, when endo-
somal cholesterol is low, ILV formation could be supported by transfer of ER-derived cholesterol at the annexin
A1-dependent ER : endosome contacts described above. Consistently, in the absence of LDL, the cholesterol
content of EGFR-containing MVBs is dependent on the extent of these contacts. Extending the contacts by
expressing ‘phospho-mimetic’ annexin A1 caused greater MVB cholesterol accumulation, whereas depleting
annexin A1 reduced MVB cholesterol content [11]. Thus, when there is a necessity for ER-derived cholesterol,
annexin A1-tethered contact sites enable the ﬂow of cholesterol from the ER to the endosome to support ILV
formation (Figure 2).
Lipid transfer between two membranes can occur via lipid transfer proteins which can protect a lipid from
an aqueous cytosol in transit from donor to acceptor membrane [37]. ORP1L is a member of the family of
OSBP (oxysterol-binding protein)-related proteins (ORPs) that have a conserved OSBP-related domain that can
bind lipids. The founding member of the ORP family, OSBP, was originally identiﬁed by its ability to bind oxy-
sterols, but further studies have found that many ORPs are able to bind cholesterol [38] including ORP1L [39].
Overexpression of ORP1L expands ER : endosome contacts via a sterol-sensitive interaction with ER-localised
VAPs (VAMP-associated protein) [14] via a conserved FFAT motif found in many VAP-binding proteins [40].
Although Eden et al. [11] found that depletion of ORP1L or VAPs had little effect on the formation of contacts
between EGFR-containing MVBs and the ER, ORP1L depletion did reduce both the amount of cholesterol and
the number of ILVs present in the MVBs in the absence of LDL [11]. Cholesterol content and ILV formation
could be restored by re-expressing wild-type but not mutant ORP1L deﬁcient in VAP binding. ORP1L is
recruited to endosomes via Rab7 [41], a marker of mature MVBs and lysosomes, and yet ILV formation in
EGFR-containing MVBs begins early in the endocytic pathway, rapidly after EGFR stimulation. Intriguingly, a
pool of ORP1L was found to associate with EGFR-containing MVBs, regardless of cholesterol status, where it
was recruited to membrane contact sites with the ER in the absence of LDL [11]. Thus, the ORP1L : VAP inter-
action that was previously shown to be promoted by low sterol conditions [14] appears necessary for cholesterol
transport from the ER to EGFR-containing MVBs at annexin A1-dependent contacts to support ILV formation
(Figure 2).
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Whilst ORP1L is involved in ER cholesterol transfer to EGFR-containing endosomes, another lipid transfer
protein, StARD3, has been implicated in transfer of cholesterol from the ER to endosomes in
non-EGF-stimulated cells (Figure 2). StARD3 is a member of a major family of lipid transfer proteins, many of
which have been shown to transfer sterol via its conserved StART (Steroidogenic Acute Regulatory lipid
Transfer protein) domain, a helix-grip fold with a lipid-binding cavity [42]. ORP1L and StARD3 have been
shown to be recruited to separate populations of endosomes [43] but, like ORP1L, StARD3 has a FFAT motif,
able to interact with VAPs on the ER and its overexpression promotes ER contact site formation with MVBs
[15]. In a recent study, StARD3 overexpression was shown to increase endosomal cholesterol at the expense of
the plasma membrane and increase numbers of internal membranes including ILVs, within MVBs of
non-EGF-stimulated cells [44]. These effects depended on the StART domain of STARD3 and the ability of
StARD3 to bind VAP, strongly suggesting that StARD3 transfers ER-derived cholesterol at ER : endosome
contact sites. In this study, in vitro assays were established that directly tested the activity of StARD3 in choles-
terol transfer. Although soluble StARD3 (without the transmembrane domain) was able to transfer cholesterol
between donor and acceptor liposomes, the speed of the activity was 20 times faster when StARD3 was
anchored to ‘endosome-like’ acceptor liposomes and VAP was anchored to ‘ER-like’ donor liposomes. Under
these conditions the liposomes aggregated, modelling contact site formation. Mutation of the FFAT motif
which regulates VAP interaction, abolished liposome aggregation and reduced sterol transfer to speeds compar-
able to soluble StARD3, consistent with fast cholesterol transfer occurring at donor : acceptor liposome
contacts.
Figure 2. Illustration of ILV formation in the absence of LDL-derived cholesterol.
Without access to LDL, cells increase cholesterol synthesis in the ER to meet cellular demand for cholesterol. ILVs contain high
concentrations of cholesterol and the formation of ILVs in the absence of endocytosed LDL requires ER-derived cholesterol. In
these conditions, ER : endosome membrane contacts expand to provide sites for cholesterol transfer. (A) In EGFR-positive
MVBs, ER : endosome membrane contacts are formed by annexin A1 : S100A11 heterotetramers. These contacts allow PTP1B
to interact with EGFR and ESCRT0. ORP1L is also recruited to the annexin A1-dependent contacts to facilitate cholesterol
transfer from the ER to endosomes via interaction with VAP on the ER. (B) ORP1L is also recruited to EGFR-negative
endosomes where it expands contacts with the ER via interaction with VAPs and is potentially well placed to carry out
cholesterol transfer activity. (C) StARD3 is present on endosomes distinct from those positive for ORP1L. StARD3 has been
shown to promote expansion of ER : endosome contacts via interaction with VAPs and to transfer cholesterol from the ER to
the endosomes to support ILV formation. Abbreviations: EGF, epidermal growth factor; EGFR, EGF receptor; ESCRT,
Endosomal Sorting Complex Required for Transport; ILV, intraluminal vesicle; LDL, low-density lipoprotein; ORP1L,
OSBP-related protein 1-like; P, phosphate group; PTP1B, protein tyrosine phosphatase 1B; StARD3, Steroidogenic Acute
Regulatory lipid transfer protein 3; Ub, ubiquitin; VAPA/B, VAMP-associated protein A/B.
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Recently, MOSPD2 (motile sperm domain-containing protein 2) was identiﬁed as another ER-resident
protein that, like VAP, binds FFAT motif-containing proteins (including ORP1L and STARD3) and is required
for ER–endosome contact site formation. The function of MOSPD2-regulated contacts is not yet understood,
but MOSPD2 contains a CRAL-TRIO domain, suggesting a likely role in lipid transport [45].
Potential future directions
Although the role of ESCRT0 in sorting ubiquitinated cargo for incorporation onto ILVs is relatively well estab-
lished, the way in which this activity is regulated by phosphorylation/dephosphorylation is far from clear.
ESCRT0 phosphorylation occurs on endosomes but whether or not this happens within clathrin-coated
domains is unknown. ESCRT0 dephosphorylation likely occurs at ER : endosome contact sites, but the relation-
ship of the contacts with clathrin-coated domains is unclear. Both the clathrin coat and ER : endosome mem-
brane contact sites must be disassembled before scission of the ILV but how this is regulated is largely
unknown, although the AAA ATPase, Vps 4, has been implicated in clathrin coat dissociation [46]. At least
one component of ESCRT0, Hrs, has other less well-characterised functions that appear to be independent of
the later ESCRT machinery. Hrs has been implicated in recycling of heterotrimeric G protein-coupled receptors
[47], a function that is apparently opposed to ESCRT-dependent sorting to the lysosome. Hrs (and Vps4) have
also been implicated in egress of LDL-derived cholesterol from endosomes to the ER [48,49], i.e. in the oppos-
ite direction to the transport of ER-derived cholesterol to endosomes at membrane contact sites to support ILV
formation (described above). Since ER–endosome contact sites (and, most likely, PTP1B-mediated dephosphor-
ylation of Hrs) are increased under conditions of low LDL [11,14], there may be reciprocal regulation of Hrs
function and the sterol environment of the endocytic pathway. It is tempting to speculate that regulation of Hrs
phosphorylation at membrane contact sites between the endocytic pathway and the ER co-ordinates the mul-
tiple ESCRT-dependent and -independent roles of Hrs. Hopefully, tools that allow not only contact site assem-
bly but also disassembly to be manipulated will allow their role in regulation of ESCRT0 phosphorylation and
function to be established.
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